Acute lymphoblastic leukaemia: a heterogenous disease

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Acute lymphoblastic leukaemia (A.L.L.) is a significant hematologic malignancy.
• Understanding the immunophenotype of A.L.L. is crucial for diagnosis and classification.

Purpose of the Study:

• To investigate the surface marker expression on lymphoblasts in A.L.L. cases.
• To determine the lineage origin (T-cell or B-cell) of neoplastic cells in A.L.L.

Main Methods:

• Utilized multiple techniques to detect surface markers on T and B lymphocytes.
• Analyzed 11 cases of A.L.L. for lymphoblast surface marker expression.
• Assessed rosetting assays (sheep red blood cells, Fc receptors) and surface immunoglobulin detection.

Main Results:

• Four cases showed minimal surface marker expression on lymphoblasts.
• One case indicated a T-cell origin with sheep red blood cell and Fc rosette formation.
• Another case suggested a B-cell origin due to Fc and C3 receptor presence.
• Five cases displayed detectable surface immunoglobulin on 14-43% of blasts.

Conclusions:

• A.L.L. is a heterogeneous disease with varying surface marker expression.
• Some A.L.L. cases fail to express identifiable surface markers.
• A.L.L. can originate from either T-lymphocyte or B-lymphocyte precursors, or exhibit dual characteristics.